key: cord-0974135-rfdnddcb
authors: Cooper, D. J.; Lear, S.; Watson, L.; Shaw, A.; Ferris, M.; Doffinger, R.; Bousfield, R.; Sharrocks, K.; Weekes, M.; Warne, B.; Sparkes, D.; Jones, N. K.; Rivett, L.; Routledge, M.; Chaudhry, A.; Dempsey, K.; Matson, M.; Lakha, A.; Gathercole, G.; O'Connor, O.; Wilson, E.; Shahzad, O.; Toms, K.; Thompson, R.; Halsall, I.; Halsall, D.; Houghton, S.; Papadia, S.; Kingston, N.; Stirrups, K.; Graves, B.; Walker, N.; Stark, H.; The CITIID-NIHR BioResource COVID-19 Collaboration,; De Angelis, D.; Seaman, S.; Bradley, J.; Török, M. E.; Goodfellow, I. G.; Baker, S.
title: A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital
date: 2020-11-04
journal: nan
DOI: 10.1101/2020.11.03.20220699
sha: 60f95d0306f91a654a10868ca8c2b35a4f1ea23f
doc_id: 974135
cord_uid: rfdnddcb

Background The COVID-19 pandemic continues to grow at an unprecedented rate. Healthcare workers (HCWs) are at higher risk of SARS-CoV-2 infection than the general population but risk factors for HCW infection are not well described. Methods We conducted a prospective sero-epidemiological study of HCWs at a UK teaching hospital using a SARS-CoV-2 immunoassay. Risk factors for seropositivity were analysed using multivariate logistic regression. Findings 410/5,698 (7.2%) staff tested positive for SARS-CoV-2 antibodies. Seroprevalence was higher in those working in designated COVID-19 areas compared with other areas (9.47% versus 6.16%) Healthcare assistants (aOR 2.06 [95%CI 1.14-3.71]; p=0.016) and domestic and portering staff (aOR 3.45 [95% CI 1.07-11.42]; p=0.039) had significantly higher seroprevalence than other staff groups after adjusting for age, sex, ethnicity and COVID-19 working location. Staff working in acute medicine and medical sub-specialities were also at higher risk (aOR 2.07 [95% CI 1.31-3.25]; p=0.002). Staff from Black, Asian and minority ethnic (BAME) backgrounds had an aOR of 1.65 (95% CI 1.32-2.07; p<0.0001) compared to white staff; this increased risk was independent of COVID-19 area working. The only symptoms significantly associated with seropositivity in a multivariable model were loss of sense of taste or smell, fever and myalgia; 31% of staff testing positive reported no prior symptoms. Interpretation Risk of SARS-CoV-2 infection amongst HCWs is heterogeneous and influenced by COVID-19 working location, role, age and ethnicity. Increased risk amongst BAME staff cannot be accounted for solely by occupational factors. Funding Wellcome Trust, Addenbrookes Charitable Trust, National Institute for Health Research, Academy of Medical Sciences, the Health Foundation and the NIHR Cambridge Biomedical Research Centre.

Evidence before this study 89 Specific risk factors for SARS-CoV-2 infection in healthcare workers (HCWs) are not well defined. 90

Additionally, it is not clear how population level risk factors influence occupational risk in defined 91 demographic groups. Only by identifying these factors can we mitigate and reduce the risk of 92 occupational SARS-CoV-2 infection. We performed a review of the evidence for HCW-specific risk 93 factors for SARS-CoV-2 infection. We searched PubMed with the terms "SARS-CoV-2" OR 94 "COVID-19" AND "Healthcare worker" OR "Healthcare Personnel" AND "Risk factor" to identify 95 any studies published in any language between December 2019 and September 2020. The search 96 identified 266 studies and included a meta-analysis and two observational studies assessing HCW 97 cohort seroprevalence data. Seroprevalence and risk factors for HCW infections varied between 98 studies, with contradictory findings. In the two serological studies, one identified a significant 99 increased risk of seroprevalence in those working with COVID-19 patients (Eyre et al 2020), as well 100 as associations with job role and department. The other study (Dimcheff et al 2020) found no 101 significant association between seropositivity and any identified demographic or occupational factor. 102 confirmed COVID-19 cases and identifying as being within specific ethnic groups (BAME staff). We 115 further delineated the risk amongst BAME staff and demonstrate that occupational factors alone do 116 not account for all of the increased risk amongst this group. We demonstrate for the first time that 117 healthcare assistants represent a key at-risk occupational group, and challenge previous findings of 118 significantly higher risk amongst nursing staff. Seroprevalence in staff not working in areas with 119 confirmed COVID-19 patients was only marginally higher than that of the general population within 120 the same geographical region. This observation could suggest the increased risk amongst HCWs 121 arises through occupational exposure to confirmed cases and could account for the overall higher 122 seroprevalence in HCWs, rather than purely the presence of staff in healthcare facilities. 123

Over 30% of seropositive staff had not reported symptoms consistent with COVID-19, and in those 124 who did report symptoms, differentiating COVID-19 from other causes based on symptom data alone 125 was unreliable. 126 127 Implications of all the available evidence 128

International efforts to reduce the risk of SARS-CoV-2 infection amongst HCWs need to be 129 prioritised. The risk of SARS-CoV-2 infection amongst HCWs is heterogenous but also follows 130 demonstrable patterns. Potential mechanisms to reduce the risk for staff working in areas with 131 6 143 Background 144

With >30 million cases and >1 million deaths reported to date globally, the ongoing COVID-19 145 pandemic continues to impact daily life 1 . A nationwide lockdown in the UK on 23 rd March 2020 146 succeeded in slowing infection rates 2 ; however, a rising number of infections are now being observed 147 with the easing of lockdown measures 3 . The logistics of managing patients with COVID-19 presented 148 unique challenges to hospitals and NHS trusts across the UK; evidence and practices evolved rapidly 149 as experience was gained. Healthcare workers (HCWs) are at a higher risk of SARS-CoV-2 infection 150 than the general population 4,5 , and some contradictory evidence is emerging for risk factors associated 151 with SARS-CoV-2 infection in front-line HCWs 6-8 . Protecting HCWs by identifying risk factors for 152 SARS-CoV-2 infection as the UK continues to see an increase in COVID-19 diagnoses is paramount 3 . 153

Controlling transmission within a hospital setting, as well as from hospitals back into the community, 154

is key for controlling the pandemic 9,10 . However, defining HCW specific risk-factors remains a 155 challenge. Additionally, higher rates of symptomatic SARS-CoV-2 infection, hospitalisation and 156 death have been observed amongst patients from ethnic minority populations in the UK 11 An asymptomatic staff screening programme using SARS-CoV-2 PCR testing was established in 184

April 2020 18 . A staff screening programme for SARS-CoV-2 serological testing was commenced on 185 the 10 th June 2020. All staff members were invited by email to participate in the serological screening 186 programme and asked to self-refer for a clinic appointment. Written informed consent was obtained 187 from all participants. As part of this process all participants were invited to join the NIHR 188

BioResource -COVID-19 Research Cohort (IRAS 220277). At enrolment, participants completed a 189 questionnaire asking about demographic characteristics, healthcare role, ethnicity, previous symptoms 190 consistent with COVID-19 and previous results of SARS-CoV-2 PCR testing. A total of 7·8 ml of 191 blood was collected, including one serum sample and one whole blood sample. The serum sample was 192 assayed for total SARS-CoV-2 antibody; both residual serum and whole blood were stored for future 193 analyses. 194 195 Laboratory assays 196 Serological testing for antibodies directed against SARS-CoV-2 was performed using the Centaur XP automated high throughput enzyme linked chemiluminescent bridging immunoassay which targets the 199 S1RBD antigen of SARS-CoV-2 and can detect all Ig subclasses (IgG, IgM, and IgA 

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020. ;

The CUH staff serology screening clinic was operational between 10 th June and 7 August 2020. A 226 total of 8,376 (73%) staff attended the clinic for SARS-CoV-2 serology; 5,697/8,376 (68%) of these 227 consented to be enrolled in the study ( Figure 2 ). 1,700/5,967 (28·5%) of study participants reported 228 that they had worked in a designated COVID-19 area within the CUH structure during the peak of the 229 epidemic between February and June 2020. The median age of participants was 38 years (range 17-83 230 years) and 22·7% (1,293/5,697) The overall seroprevalence of total SARS-CoV-2 antibodies amongst all staff in this study was 7·2% 236 (410/5,698). Amongst those reporting having worked in a dedicated COVID-19 area between 237

February and June 2020, the seroprevalence increased to 9·5% (169/1,784; Table 2 ). Conversely, the 238 comparable seroprevalence in those reporting they had never worked in COVID-19 area was 6·2% 239 (241/3,913; p<0·0001). The prevalence of seropositivity in male staff (8·0%; 104/1293) was not 240 significantly different (p=0·18) than that observed in female staff (6·95%; 306/4404). The risk of 241 seropositivity decreased with age, with an odds ratio (OR) of 0·83 (95% CI 0·76 -0·91) for every 10-242

year increase in age (p<0·0001 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20220699 doi: medRxiv preprint Division/department 254 Staff departments at CUH are separated into six "Divisions" (Table 3 ). Risk differed significantly by 255 division (p value for the likelihood ratio test of the overall effect of division <0·001). Staff working 256 within Division C (primarily acute medicine, medical sub-specialities and Emergency Department) 257 had a significantly higher seroprevalence (OR 2·8 [95% CI 1·82 -4·33] p<0·0001) compared to staff 258 working in Division E (paediatrics and maternity), who had the lowest seroprevalence (5·0%; 38/741). 259

Staff working specifically in the ICUs had a seroprevalence of 6·33% (10/158), and staff working 260 specifically in the Emergency Department had a seroprevalence of 9·1% (9/99). However, neither of 261 these staff groups had significantly different seropositivity using univariate analysis (p>0·1 in both 262 groups) compared to non-ICU and non-Emergency Department staff respectively. 263 264 Ethnicity 265

We observed substantial heterogeneity in the proportion of seropositivity between self-reported ethnic 266 groups ( Figure 4 ). The aORs in Asian and 293 black staff in the multivariable model were 1·69 (95% CI 1·30 -2·19; p<0·0001) and 3·42 (95% CI 294 2·12 -5·53; p<0·0001), respectively (Table 2 ). There was no significant evidence that the effect of 295 ethnicity was modified by COVID working location (p value of interaction 0·96), and we also 296 observed a similar increase in risk associated with ethnicity when data were stratified by CUH 297 COVID-19 working location. For Asian staff, the aOR for seroconversion was 1·59 (95% CI 1·09 -298 2·32; p=0·016) for those working in COVID-19 areas compared to 1·76 (95% CI 1·21 -2·55; 299 p=0·003) for those not working in COVID-19 areas. For black staff the aOR for seroconversion when 300 working in COVID-19 areas was 3·91 (95% CI 1·78 -8·59; p=0·001), compared to 3·06 (95% CI 1·65 301 -5·64; p<0·001) who reported working in a non-COVID-19 area. 302

The aOR for seropositivity in staff self-reporting as BAME (as a binary variable compared to white 304 staff in a separate multivariable model) was 1·65 (95% CI 1·32 -2·07; p<0·0001) after controlling for 305 age, sex, job role and COVID-19 working location. For staff self-reporting as BAME, the aOR for 306 seroconversion was 1·59 (95% CI 1·13 -2·23; p=0·007) for those working in COVID-19 areas and 307 1·68 (95% CI 1·23 -2·39; p=0·001) for those who reported not working in a COVID-19 area during 308 the epidemic. 309 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20220699 doi: medRxiv preprint

Participants were asked about any symptoms consistent with COVID-19 since February 2020. 312

Critically, seroprevalence was significantly higher in the group with symptoms (17·2%; 266/1,548) in 313 comparison to those without symptoms (3·1%; 117/3827, p<0·0001). Almost 31% (126/410) of 314 seropositive HCWs reported not having any symptoms consistent with COVID-19 since February 315 2020. After adjusting for age, sex and ethnicity, the aOR of seropositivity was 6·97 (95% CI 5·54 -316 8·78; p<0·0001) in the group who reported prior symptoms compared to those who did not. The loss 317 of the sense of taste or smell was the strongest predictor of seropositivity on univariate analysis; 318 however, only 44% (154/351) of those reporting the loss of taste or smell were seropositive (Table 5) . 319

In a multivariable logistic regression model containing all collected symptoms ( February 2020 and the time of blood sampling, primarily through the CUH HCW testing programme. 329

Of these, 51 (2·05%) tested PCR positive for SARS-CoV-2 RNA, 47 had detectable SARS-CoV-2 330 antibodies, and four had no detectable SARS-CoV-2 antibodies. The median SARS-CoV-2 PCR Ct 331 value in those who seroconverted was 30 (IQR 24 -34), in comparison to 36 (IQR 35·5 -37) in those 332 who did not seroconvert (p=0·006). The four staff who had previously tested SARS-CoV-2 PCR 333 positive and were antibody negative all reported having symptoms consistent with COVID-19 334 infection at the time of PCR testing, although none reported the loss of taste or smell. Nine (18%) of 335 the staff previously testing SARS-CoV-2 PCR positive, and who were antibody positive, were 336 asymptomatic at the time of PCR testing. 337 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20220699 doi: medRxiv preprint

In this comprehensive assessment of factors associated with seropositivity for SARS-CoV-2 340 antibodies in HCWs at a large UK tertiary referral centre we were able to identify key at-risk 341 occupational groups. Specifically, staff working in areas where patients with confirmed SARS-CoV-2 342 infection are cared for, those employed as HCA or domestic and portering staff, those of younger age, 343 and those working in acute medicine or a medical sub-speciality were more likely to have SARS-344

CoV-2 antibodies. A reduced risk of SARS-CoV-2 seropositivity was associated with White ethnicity, 345 being employed in an administrative role or working in paediatric or maternity services, and 346 belonging to an older age group. 347

We found that the seroprevalence of SARS-CoV-2 antibodies in staff working in non-COVID facing 349 areas was slightly higher (6·16%) than in the general population in the East of England (5·0%) 21 and 350 comparable to the national prevalence (6·0%) 21 . This is in keeping with previous retrospective 351 serological HCW studies reporting relatively low seroprevalences in Germany (1·6%) 22 , Wuhan 352 (3·8%) 23 and Belgium (7·6%) 24 . Amongst Asian staff working at CUH the seroprevalence was also 353 comparable to East of England data (10·5% vs 10·1%, respectively), as was the seroprevalence 354 amongst Black staff at CUH compared to regional data (18% vs 15%, respectively) 21 . Overall, we 355 observed significantly higher seroprevalence in all BAME staff compared to White staff, and to a 356 greater extent in Black and Asian staff specifically. These differences have been observed nationally 357 and are not unique to HCWs. The finding that the increased risk associated with BAME staff was not 358 influenced by COVID-19 area working, as well as the ethnic differences in symptomatic 359 seroconversion rates, demonstrates that the increased prevalence of antibodies in BAME HCWs 360 cannot be accounted for by purely occupational factors. 361

In staff who were previously SARS-CoV-2 PCR positive, 92% (47/51) had detectable antibodies. 363

There was a significant difference in Ct values between those who did and did not seroconvert. A 364 potential explanation for this difference is that higher viral loads may be required to generate a 365 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020. ; sustained antibody response. Alternatively, a false positive SARS-CoV-2 PCR result or the detection 366 of viral nucleic acid without infectious virus would also explain a lack of seroconversion. 367 368 Consistent with previous studies, we demonstrate that whilst reporting prior symptoms consistent with 369 COVID-19 increased the chances of seropositivity, differentiating previous COVID-19 infection from 370 other common respiratory tract infections based on symptoms alone is unreliable 6 . Interestingly, the 371 only symptoms that significantly predicted seropositivity on a multivariable logistic regression model 372 were the loss of sense of taste or smell, myalgia and fever. Prior reporting of cough or shortness of 373 breath were not good predictors of the presence of SARS-CoV-2 antibodies in a multivariable model. 374

These data also reiterate previous findings that asymptomatic SARS-COV-2 infection amongst 375 healthcare workers is common, with 31% of seropositive staff having never reported consistent 376 symptoms, and 18% of PCR positive staff never having reported consistent symptoms. These data 377 highlight the importance of the contribution of the asymptomatically infected population to the spread 378 of the disease 25,26 . Consequently, asymptomatic screening of staff in healthcare settings should 379 become a component of routine disease survelliance 6,18,27 . 380

We acknowledge several limitations to our study. Variables such as ethnicity, COVID-working 382 location and job role were self-reported; however, we have no reason to think these variables were 383 party to recall bias and it is unlikely to impact on the results to any large degree. The proportion of 384 staff reporting being of Black ethnicity was relatively small, although the proportion of BAME staff is 385 consistent with the wider NHS workforce, and our conclusions are therefore broadly generalisable. 386

The terminology and designation of COVID-facing clinical areas was an evolving factor throughout 387 PPE and adherence to PPE protocols in this study design. The selected assay may have reduced 394 sensitivity in individuals who generated robust antibody responses to other SARS-COV-2 antigens or 395 those producing low affinity antibodies during early disease. Similar considerations apply to other 396 commercial assays 28 , and a recent comparison demonstrated assay equivalence with the selected 397 platform having higher accuracy 19 , and an independently reported sensitivity and specificity of 98·1% 398 (95% CI 96·6 -99·1) and 99·1% (95% CI 99·4 -100) respectively 19 . We also note that symptom data 399 were recorded retrospectively, and may have been subject to recall bias. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 5 : Unadjusted odds ratio (OR) and adjusted odds ratio (aOR) of SARS-CoV-2 seropositivity by reported symptoms All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 4, 2020.

; https://doi.org/10.1101/2020.11.03.20220699

doi: medRxiv preprint

World Health Organisation. Coronavirus disease (COVID-2019) situation reports

COVID-19 spread 431 in the UK: the end of the beginning?

COVID-19 map

Risk of COVID-19 among frontline healthcare 435 workers and the general community: a prospective cohort study

COVID-19 in Healthcare Workers: A Living 437

Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and 438 Outcomes

Reasons for healthcare workers becoming infected with novel 449 coronavirus disease 2019 (COVID-19) in China

Ethnicity and risk of death in patients hospitalised for 451

COVID-19 infection in the UK: an observational cohort study in an urban catchment area

Racial and ethnic disparities in SARS-CoV-2 454 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population

Patients and White Patients with Covid-19

Deaths in healthcare workers due to COVID-19: the 460 need for robust data and analysis

Antibody prevalence for SARS-CoV-2 in England 477 following first peak of the pandemic: REACT2 study in 100,000 adults

SARS-CoV-2-specific antibody detection in healthcare 480 workers in Germany with direct contact to COVID-19 patients

Seroprevalence of immunoglobulin M and G antibodies against 482 SARS-CoV-2 in China

Hospital-Wide SARS-CoV-2 Antibody Screening in 484 3056 Staff in a Tertiary Center in Belgium

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative 486

COVID-19 transmission through asymptomatic carriers is a challenge to 488 containment

Frontline Health Care Personnel in a Multistate Hospital Network -13 Academic Medical Centers

Public Health England. Evaluation of sensitivity and specificity of four commercially 493

Ethnicity White (n, %)

*** *** * * p<0.05 *** p<0.001